Clinical trial
Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose…
NCT00154284 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00154284 |
|---|---|
| Title | Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients |
| Official title | A 12 Month, Multicenter, Randomized, Parallel, Open-label Study, to Evaluate Renal Function and Efficacy of Everolimus With Basiliximab and Cyclosporine Microemulsion Discontinuation at 3 Month Post-transplant Versus Minimization, in de Novo Kidney Transplant Recipients |
| Acronym | CERTES02 |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Organ Transplantation, Renal Transplantation |
| Intervention type | Drug |
| Interventions | Everolimus (Certican), Cyclosporine (Neoral), Steroid, Basiliximab (Simulect) |
| Enrollment | 114 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 9, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: